Home
About
FAQ
History (38)
Hip arthroscopy in patients with early arthritis.
Dermatitis, Irritant
Development and Validation of an Older Occupant Finite Element Model of a Mid-Sized Male for Investigation of Age-related Injury Risk.
SES IMPACT ON RACIAL DIFFERENCES IN STROKE MORTALITY
Pharmacoeconomic Considerations in Treating Actinic Keratosis: An Update.
See All 38 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pharmacoeconomic Considerations in Treating Actinic Keratosis: An Update.
Vale SM, Hill D, Feldman SR. Pharmacoeconomic Considerations in Treating Actinic Keratosis: An Update. Pharmacoeconomics. 2017 02; 35(2):177-190.
View in:
PubMed
subject areas
Aged
Cost-Benefit Analysis
Dermatologic Agents
Economics, Pharmaceutical
Humans
Keratosis, Actinic
Medication Adherence
Photochemotherapy
Practice Guidelines as Topic
Risk Factors
Skin Neoplasms
authors with profiles
Steven R. Feldman MD, PhD